CALL US +44 (0)1462 440 084 | +1 919-882-2016 | Contact | Submit RFI

The Analysis of Direct and Indirect Pathways in Observational Studies

Posted by Statistical Consultancy Team on Tue, Oct 17, 2017

Methods for assessing early-phase equivalence in Biosimilars

Posted by Statistical Consultancy Team on Mon, Sep 25, 2017

Is a MSc in Statistics the ‘be-all and end-all’ to a career as a pharmaceutical statistician?

Posted by Statistical Consultancy Team on Thu, Sep 14, 2017

Top 3 Examples of Interactive Clinical Data Visualizations

Posted by Statistical Consultancy Team on Tue, Sep 05, 2017

The Trend in Biosimilar Development and Recent FDA Guidance

Posted by Statistical Consultancy Team on Tue, Jun 27, 2017

The Logic of a Clinical Research Organization Programmer

Posted by Clinical Programming Team on Fri, Jun 23, 2017

The INTO Statement in PROC SQL to Create Macro Variables

Posted by Clinical Programming Team on Fri, Jun 09, 2017

Therapeutic Areas for Wearable Devices in Clinical Trials

Posted by Statistical Consultancy Team on Fri, Mar 31, 2017

The History of Pharmacovigilance Infographic

Posted by Pharmacovigilance Team on Mon, Mar 27, 2017

Medical Coding in Clinical Data Management

Posted by Clinical Data Management Team on Mon, Mar 20, 2017

ICHGCP E6 Addendum R2 - What do you need to know?

Posted by Gavin Boodoo on Mon, Feb 13, 2017

The Cost Considerations of Outsourcing to a Clinical Research Organization

Posted by Commercial Team on Mon, Feb 06, 2017

Making Metric Collection Obligatory in Clinical Trial Contracts

Posted by Medical Writing Team on Tue, Jan 24, 2017

Should We Be Integrating Mobile Health Apps in Clinical Trials?

Posted by Statistical Consultancy Team on Fri, Dec 09, 2016

A Review of the Annual PhUSE 2016 Conference

Posted by Clinical Programming Team on Wed, Nov 30, 2016

The Evolution of Risk Based & Remote Monitoring

Posted by Gavin Boodoo on Fri, Nov 25, 2016

A Guide to the Benefits of Centralized Clinical Data

Posted by Commercial Team on Fri, Nov 18, 2016

How Well Written Proposals Affect Clinical Research Organization Selection

Posted by Commercial Team on Fri, Oct 28, 2016

Integrated Summaries of Safety & Efficacy for Regulatory Submissions

Posted by Statistical Consultancy Team on Wed, Oct 19, 2016

Creating High Quality Graphics in Clinical SAS Programming

Posted by Statistical Consultancy Team on Tue, Oct 11, 2016

Delayed-entry models using PROC PHREG in Survival Analysis

Posted by Statistical Consultancy Team on Fri, Sep 16, 2016

Electronic Data Capture Systems In Clinical Data Management: The myths and the reality

Posted by Clear Clinica on Fri, Sep 09, 2016

The Rise of Risk Based Monitoring [Infographic]

Posted by Thomas Underwood on Tue, Aug 16, 2016

Assessing Equivalence in Rheumatoid Arthritis in Clinical Trials

Posted by Statistical Consultancy Team on Fri, Jul 29, 2016

mHealth Apps and Wearables in Clinical Trials to Consider

Posted by Nick Burch on Thu, Jun 30, 2016

Is Lack of Data the Biggest Challenge for Early Phase Pharmacovigilance?

Posted by Pharmacovigilance Team on Thu, Jun 23, 2016

Understanding the Proportional Odds Assumption in Clinical Trials

Posted by Statistical Consultancy Team on Fri, Jun 10, 2016

Celebrating International Clinical Trials Day

Posted by Marketing Quanticate on Fri, May 20, 2016

The Role of a Statistician In a Pre-Clinical Study

Posted by Statistical Consultancy Team on Fri, May 13, 2016

Regulatory Writing – An Integral Part of Clinical Research

Posted by Medical Writing Team on Fri, May 06, 2016

The Rise of Risk-Based Monitoring in Clinical Trials

Posted by Thomas Underwood on Tue, Apr 26, 2016

The Different Phases of Clinical Trials

Posted by Medical Writing Team on Fri, Apr 15, 2016

A Guide to Phase 1 Clinical Trial Designs

Posted by Statistical Consultancy Team on Fri, Apr 08, 2016

Exploring CDISC Analysis Data Model (ADaM) Datasets

Posted by Clinical Programming Team on Wed, Mar 30, 2016

Preparing for Big Data in Pharma

Posted by Nick Burch on Thu, Mar 17, 2016

Celebrating Women in Science, Medicine and Mathematics

Posted by Marketing Quanticate on Tue, Mar 08, 2016

Outcomes Research Programming vs Traditional Clinical Trial Programming

Posted by Clinical Programming Team on Tue, Mar 01, 2016

Compiling the Appendices for a Clinical Study Report

Posted by Medical Writing Team on Fri, Feb 19, 2016

4 Efficiencies of a Clinical Research Organization

Posted by Commercial Team on Fri, Feb 05, 2016

Comparing treatment response curves: a practical example in rheumatoid arthritis

Posted by Statistical Consultancy Team on Thu, Jan 21, 2016

Integrated Summary Tips

Posted by Medical Writing Team on Fri, Jan 15, 2016

Creating Custom or Non-Standard CDISC SDTM Domains

Posted by Clinical Programming Team on Fri, Jan 08, 2016

Key Considerations When Progressing With an FSP Relationship

Posted by Karen Smith on Mon, Dec 14, 2015

Conducting Randomization in Clinical Trials [VIDEO]

Posted by Statistical Consultancy Team on Fri, Dec 04, 2015

The Challenges of Writing Patient / Safety Narratives

Posted by Medical Writing Team on Tue, Nov 24, 2015

How the Hierarchy of Teams Affects the Cost of Clinical Development

Posted by Daniel Chapple on Tue, Sep 15, 2015

Your SAS Secrets Exposed! [4 SAS Tips]

Posted by Clinical Programming Team on Tue, Jul 14, 2015

7 Considerations of Global Resources in Clinical Development Partnerships

Posted by Daniel Chapple on Fri, May 29, 2015

Nick Burch Discusses Big Data in Clinical Trials [Video]

Posted by Nick Burch on Fri, Apr 24, 2015

Remote Monitoring During Clinical Trials, a Risk Based Approach

Posted by Medical Writing Team on Fri, Apr 10, 2015

The Creation of ADaM Datasets for Pharmacokinetic (PK) Analysis [Video]

Posted by Clinical Programming Team on Thu, Mar 26, 2015

Total Value Ownership of selecting a partner for Clinical Development

Posted by Daniel Chapple on Mon, Mar 16, 2015

Ben Goldacre Discusses Clinical Data Transparency [Video]

Posted by Statistical Consultancy Team on Mon, Feb 23, 2015

An Overview of Efficacy Endpoints in Oncology Studies

Posted by Clinical Programming Team on Fri, Jan 09, 2015

How will the change in European Device Regulations affect vigilance practices?

Posted by Pharmacovigilance Team on Thu, Dec 11, 2014

Utilizing a Bayesian Informative Prior to Reduce Sample Size in Clinical Trials

Posted by Statistical Consultancy Team on Thu, Nov 13, 2014

How Big is Big Data in Clinical Trials – Tall, Grande, Venti Data?

Posted by Nick Burch on Fri, Aug 29, 2014

Hitting New Targets - EPC Interview with David Underwood

Posted by David Underwood on Mon, Aug 18, 2014

Data Transparency in Clinical Trials Q&A with Ben Goldacre [Video]

Posted by Statistical Consultancy Team on Fri, Jul 18, 2014

Is Multiple Imputation in Clinical Trials Worth the Effort?

Posted by Statistical Consultancy Team on Mon, Jun 30, 2014

Efficient Data Reviews and Quality in Clinical Trials [Video]

Posted by Statistical Consultancy Team on Fri, Jun 13, 2014

Prentice-Wilcoxon Test for Paired Time-to-Event Data

Posted by Statistical Consultancy Team on Fri, May 16, 2014

7 Frequently asked Questions on Clinical Study Design

Posted by Statistical Consultancy Team on Fri, Jan 31, 2014

Longitudinal Observational Data in a Paediatric Disease Registry

Posted by Statistical Consultancy Team on Tue, Jan 21, 2014

Using Historical Data to Inform Future Decisions in Clinical Trials

Posted by Statistical Consultancy Team on Fri, Nov 15, 2013

Pharmacovigilance - The Black Triangle and Additional Monitoring

Posted by Pharmacovigilance Team on Fri, Nov 08, 2013

Using the Statistical Programming Language R in the Pharma Industry

Posted by Statistical Consultancy Team on Mon, Oct 28, 2013

Complex Randomization in Clinical Trials Need Not Be Complex

Posted by Statistical Consultancy Team on Fri, Sep 13, 2013

Using Microsoft Excel to write SAS code in Clinical Trials

Posted by Clinical Programming Team on Mon, Sep 09, 2013

How to Deal with Large SAS Datasets in Clinical Trials

Posted by Clinical Programming Team on Tue, Aug 27, 2013

The Technology Trends advancing Clinical Development Efforts

Posted by Nick Burch on Fri, Aug 16, 2013

Overview of Receiver Operating Characteristic (ROC) Curves in SAS

Posted by Statistical Consultancy Team on Fri, Aug 09, 2013

Performing CDISC Compliant Pharmacokinetic Analyses

Posted by Statistical Consultancy Team on Fri, Jul 26, 2013

Pharmacokinetic Considerations of Biosimilars

Posted by Statistical Consultancy Team on Fri, Jul 19, 2013

Multiple Forest Plots and the use of SAS Macros

Posted by Clinical Programming Team on Fri, Jul 05, 2013

The Promise of Electronic Data Capture - How Soon is Now?

Posted by Stuart Cook on Tue, Jul 02, 2013

14 Advantages of Data Centralization and Standardization in Clinical Trials

Posted by Clinical Programming Team on Tue, Jun 18, 2013

SAS Proc Transpose VS SAS Arrays in Clinical Programming

Posted by Clinical Programming Team on Fri, Jun 07, 2013

Remote Data Capture in Clinical Trials through Smartphones, Tablets and other Mobile Devices

Posted by Michael Whitworth on Tue, May 28, 2013

SAS Business Intelligence - A Perceptive Vision in Clinical Trials

Posted by Clinical Programming Team on Wed, Jan 30, 2013

Quality Process Improvements and SOP Updates [Infographic]

Posted by Quality Assurance Team on Fri, Nov 30, 2012

How a Centralized Approach to Data Impacts Clinical Study Design

Posted by Statistical Consultancy Team on Fri, Nov 09, 2012

CDISC SDTM Therapeutic Area Domains - a Rapidly Evolving Standard?

Posted by Clinical Programming Team on Tue, Sep 11, 2012

CDISC European Interchange, Stockholm, April 2012 – a Summary

Posted by Clinical Programming Team on Fri, Jul 27, 2012

Challenges and Rewards of Working in a Clinical Research Organization

Posted by Medical Writing Team on Fri, Jul 06, 2012

Are you ready for the New Pharmacovigilance Legislation?

Posted by Pharmacovigilance Team on Fri, Jun 29, 2012

Compliant with the new Eudravigilance Medicinal Product Dictionary?

Posted by Pharmacovigilance Team on Tue, Jun 26, 2012

Making a Clinical Research Organization Project Run Smoothly

Posted by Commercial Team on Fri, Jun 08, 2012

Using CDISC SDTM to Improve Cost and Quality in Integrated Summaries

Posted by Clinical Programming Team on Wed, May 30, 2012

Survival Analysis: Lifetables and Cox Proportional Hazard Model

Posted by Clinical Programming Team on Fri, Apr 13, 2012

PK data analysis and reporting: SAS or Phoenix WinNonlin?

Posted by Statistical Consultancy Team on Thu, Feb 02, 2012

Bayesian Methods and a review of the European Statistical Forum

Posted by Statistical Consultancy Team on Fri, Dec 23, 2011

Regulatory Writing: What Does it Entail?

Posted by Medical Writing Team on Wed, Dec 14, 2011

10 Considerations of Offshore Locations to Support Clinical Trials

Posted by Daniel Chapple on Thu, Nov 24, 2011

Survival Analysis in Medical Research and Bayesian Methods

Posted by Statistical Consultancy Team on Mon, Nov 21, 2011

An Introduction to Industry Training Course Review - Statisticians in the Pharmaceutical Industry

Posted by Statistical Consultancy Team on Tue, Oct 25, 2011

How to Find Traceability Solutions For Your Outsourced Clinical Data

Posted by Michael Whitworth on Wed, Sep 28, 2011

The Use of Propensity Scoring in Pooling Data across Clinical Trials

Posted by Statistical Consultancy Team on Thu, Aug 11, 2011

Why Consider Functional Outsourcing by a Functional Service Provider?

Posted by Yvonne Moores on Thu, Aug 04, 2011

Biomarkers in Drug Development

Posted by Statistical Consultancy Team on Wed, Jun 15, 2011

Medical Writing Tips For Managing Multiple Priorities

Posted by Medical Writing Team on Thu, Jun 09, 2011

CDISC SDTM v3.1.2 Theory and Application

Posted by Clinical Programming Team on Tue, May 31, 2011

Quality Assurance in Clinical Trials – An Introduction to GCP

Posted by Quality Assurance Team on Wed, May 18, 2011

Becoming a Regulatory Writer

Posted by Medical Writing Team on Tue, Apr 19, 2011

Adaptive Design and Bayesian Methods – Controlling Time and Cost

Posted by Statistical Consultancy Team on Tue, Apr 12, 2011

Bayesian Study Design & Interim Analysis In Clinical Trials

Posted by Statistical Consultancy Team on Wed, Apr 06, 2011

An Introduction To Biostatistics In Clinical Trials

Posted by Statistical Consultancy Team on Tue, Mar 29, 2011

Economical Designs for Phase I Studies

Posted by Statistical Consultancy Team on Tue, Mar 22, 2011

Clinical SAS Programming – Working Efficiently with Large Datasets

Posted by Clinical Programming Team on Mon, Mar 14, 2011

The Benefits of Centralizing Clinical Data Services

Posted by Commercial Team on Fri, Mar 04, 2011

Welcome to the Quanticate blog

Posted by Andrew MacGarvey on Fri, Mar 04, 2011

Welcome to The Quanticate Blog

We aim to provide information and support written by our experienced staff. We want to share our knowledge and create an archive of information that you will be able to engage with, share and comment on.

Subscribe to Email Updates

Blog Suggestions

Most Read

Posts by Topic

Expand all